Filing Details

Accession Number:
0001209191-20-045200
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-05 17:16:35
Reporting Period:
2020-08-03
Accepted Time:
2020-08-05 17:16:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524338 Anthony Charles Laranjeira C/O Pacira Biosciences, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Svp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-03 2,500 $44.10 22,750 No 4 M Direct
Common Stock Disposition 2020-08-03 2,500 $52.68 20,796 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2020-08-03 2,500 $0.00 2,500 $44.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2027-06-02 No 4 M Direct
Footnotes
  1. The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Includes 546 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020.
  3. The stock option vests and becomes exercisable as to 25% of the option shares on May 1, 2018, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.